On July 25, the Longgang District Enterprise Service Conference was grandly held at Shenzhen Institute of Information Technology. The highly anticipated list of Longgang District Top 100 Emerging Enterprises was unveiled at the conference. Relying on its outstanding achievements in the innovative drug sector and strong development potential, Sungening Biological Co., Ltd. was honorably selected, standing as an important representative of the development of emerging industries in Longgang District.

As a rising powerhouse deeply rooted in the innovative pharmaceutical sector, Sungening has adhered to its corporate vision of "focusing on new drug R&D to address unmet clinical needs and safeguard human health" since its founding.
Centered on the cutting edge of innovative drug research and development, the company has built an R&D team led by high-caliber talents from home and abroad. It has overcome multiple technical challenges in antifungal therapy, metabolic lipid regulation and other fields, continuously injecting new momentum into the industry’s development.
Being selected as one of the Longgang District Top 100 Emerging Enterprises is not only high recognition of Sungening ’s innovation strength, but also full affirmation of its contributions to advancing the upgrading of the biotechnology industry and boosting high-quality regional economic development.
Looking ahead, Sungening will continue to increase R&D investment, deepen industry-university-research integration, accelerate the transformation of technological achievements, and strive to make more breakthroughs in the innovative drug space.
Upholding the honor and mission as one of the Top 100 Emerging Enterprises, the company will contribute greater Sungening strength to Longgang District’s construction of the "3+4+N+AI" industrial system and its drive to build an innovation-oriented urban district.

Longgang District Enterprise Service Conference Scene (2025)

Telephone: 0755-28967200
Email: info@sungening.com

